The BPC-157 / TB-500 blend combines two of the most researched peptides in regenerative science. BPC-157, derived from a gastric protein, accelerates angiogenesis, supports tendon and ligament healing, and protects endothelial function. TB-500, a synthetic fragment of Thymosin Beta-4, promotes cellular migration and tissue remodeling by regulating actin polymerization.
Together, these peptides offer synergistic benefits in experimental models of muscle tears, ligament damage, wound repair, and inflammation. Researchers have observed enhanced collagen formation, increased capillary growth, and faster recovery timelines when combining both compounds versus using them individually. The blend proves especially effective in studies on soft tissue recovery and chronic wound healing.
While both peptides exhibit strong safety profiles in animal studies, neither is approved for human or veterinary use. This combination remains strictly for laboratory research by qualified professionals operating under appropriate conditions.
$119.97
The BPC-157 / TB-500 peptide blend combines two widely studied synthetic peptides—BPC-157, a pentadecapeptide derived from a protein in human gastric juice, and TB-500, a synthetic analog of thymosin beta-4. Together, these peptides have been researched for their individual and synergistic activity in animal models involving soft tissue repair, inflammation modulation, and cellular regeneration. This formulation has gained interest in in vitro studies focusing on angiogenesis, tissue remodeling, and wound dynamics under controlled laboratory settings.
Research indicates that BPC-157 may support endothelial health and tissue recovery through nitric oxide pathway regulation and growth factor interaction. TB-500, modeled after thymosin beta-4, is believed to enhance cell migration and modulate actin polymerization—key processes in wound healing and angiogenesis. In rodent models, both peptides have demonstrated activity in accelerating repair processes in tendon, muscle, and nerve tissue. When used in combination, laboratory researchers have explored potential synergistic effects on cellular signaling, inflammation response, and vascular remodeling.
Studies on the BPC-157 / TB-500 peptide blend often target soft tissue regeneration, including tendon, ligament, and skeletal muscle recovery in rodent injury models. Additional investigations focus on gastrointestinal lesions, post-injury inflammation, nerve regeneration, and capillary growth under in vitro conditions. Research has also examined the peptides’ combined impact on fibroblast proliferation, extracellular matrix dynamics, and cytokine expression. These findings position the blend as a valuable subject in experimental protocols related to tissue integrity and repair biology.
Extended studies involving both peptides have considered their potential regulatory effects on systemic repair mechanisms in rodent models. TB-500’s role in vascular and lymphatic tissue development, alongside BPC-157’s influence on gastrointestinal and neural recovery pathways, provides a multidimensional framework for studying chronic injury recovery and cellular stress response. Ongoing preclinical research seeks to clarify whether co-administration enhances bioavailability or modulates feedback loops within regenerative signaling cascades.
Both BPC-157 and TB-500 have demonstrated high tolerability in non-human research models, with no significant toxicity reported in standard rodent dosing protocols. However, no human safety data has been reviewed or approved by regulatory bodies. This peptide blend is provided strictly for laboratory research purposes only. It is not approved for human or veterinary use, ingestion, injection, or any form of application outside of compliant research environments.
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.
The products offered on this website are furnished for in-vitro laboratory research only. In-vitro studies (Latin: “in glass”) are performed outside of living organisms. These products are not medicines or drugs, and they have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. Under no circumstances should these products be introduced into the human or animal body, whether by injection, ingestion, topical application, or any other route. Bodily introduction is strictly prohibited by law.
Subscribe to our newsletter to claim this offer. We do not spam or sell your info.
Gold Standard Peptides is committed to providing high-quality research chemicals to the American market.
Mon – Fri / Except Holidays
Orders placed and paid after 12 PM EST
are shipped the following business day
All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
Gold Standard Peptides is a chemical supplier. Gold Standard Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Gold Standard Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.
© 2025 Gold Standard Peptides – All Rights Reserved
Want to get 15% OFF site-wide plus a FREE keychain? Subscribe to our newsletter to claim this offer!